Recent Finacing
Recent Raise
Immunovaccine develops DepoVax, a depot-forming vaccine adjuvant platform and operates cancer vaccine programs (DPX‑Survivac, DPX‑0907) plus infectious-disease pipelines for malaria, RSV, and anthrax.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor